These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15840133)

  • 1. Parvovirus B19 and systemic sclerosis.
    Ferri C; Azzi A; Magro CM
    Br J Dermatol; 2005 Apr; 152(4):819-20. PubMed ID: 15840133
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
    Ohtsuka T; Yamazaki S
    Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvovirus B19 and systemic sclerosis.
    Ferri C; Longombardo G; Azzi A; Zakrzewska K
    Clin Exp Rheumatol; 1999; 17(2):267-8. PubMed ID: 10342065
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral infections and systemic sclerosis.
    Ferri C; Giuggioli D; Colaci M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-229. PubMed ID: 24295551
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue.
    Ohtsuka T; Yamazaki S
    Br J Dermatol; 2005 May; 152(5):1078-80. PubMed ID: 15888183
    [No Abstract]   [Full Text] [Related]  

  • 6. Human parvovirus B19 in patients with aplastic anemia.
    Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
    Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 primary infection with vasculitis: DNA identification in cutaneous lesions and sera.
    Sanz-Sánchez T; Daudén E; Moreno de Vega MJ; García-Díez A
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):618-20. PubMed ID: 16684303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
    Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
    Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
    J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of viral infections in the etiopathogenesis of systemic sclerosis.
    Moroncini G; Mori S; Tonnini C; Gabrielli A
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):3-7. PubMed ID: 23910606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The historical record is consistent with the recent finding of parvovirus B19 infection of bone marrow in systemic sclerosis patients.
    Altschuler EL
    Clin Exp Rheumatol; 2001; 19(2):228. PubMed ID: 11326495
    [No Abstract]   [Full Text] [Related]  

  • 12. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parvovirus b19 infection in HIV patient with pure red cell aplasia.
    Sanphasitvong W; Poovorawan K; Boonsuk P; Assanasen T; Na Nakorn T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1216-20. PubMed ID: 16438148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between human parvovirus B19 infection and Sjögren's syndrome.
    De Stefano R; Manganelli S; Frati E; Selvi E; Azzi A; Zakrzewska K; Marcolongo R
    Ann Rheum Dis; 2003 Jan; 62(1):86-7. PubMed ID: 12480682
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection.
    Lazzerini PE; Cusi MG; Selvi E; Capecchi M; Moscadelli V; Migliacci N; Finizola F; Laghi-Pasini F
    Joint Bone Spine; 2018 Jan; 85(1):129-130. PubMed ID: 28062379
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and management of human parvovirus B19 infection.
    Ramirez MM; Mastrobattista JM
    Clin Perinatol; 2005 Sep; 32(3):697-704. PubMed ID: 16085027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
    Seishima M; Mizutani Y; Shibuya Y; Arakawa C
    Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute encephalopathy with human parvovirus B19 infection in hereditary spherocytosis.
    Oshima K; Kikuchi A; Mochizuki S; Arai T; Oishi T; Hanada R
    Pediatr Infect Dis J; 2008 Jul; 27(7):651-2. PubMed ID: 18520445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19 (B19V) infection in systemic sclerosis patients.
    Zakrzewska K; Corcioli F; Carlsen KM; Giuggioli D; Fanci R; Rinieri A; Ferri C; Azzi A
    Intervirology; 2009; 52(5):279-82. PubMed ID: 19672101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
    Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
    J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.